Intravenous colchicine treatment for six months: Adjunctive therapy in familial Mediterranean fever unresponsive to oral colchicine

Clinical and Experimental Rheumatology

Volumn 27, Issue 2 SUPPL.53, 2009, Pages

  Rozenbaum, M ^a   Boulman, N ^a   Feld, J ^a   Avshovich, N ^a   Petrovich, S ^a   Elias, M ^a   Slobodin, G ^a   Rosner, Itzhak ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE;

ABSENCE OF SIDE EFFECTS; ADULT; CASE REPORT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADULT; COHORT STUDIES; COLCHICINE; CYTOSKELETAL PROTEINS; DRUG RESISTANCE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MUTATION; TUBULIN MODULATORS;

EID: 70350163026     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. LIVNEH A, LANGEVITZ P, ZEMER D et al.: Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-1885 (Pubitemid 27452541)
2. LIDAR M, KEDEM R, LANGEVITZ P, PRAS M, LIVNEH A: Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine. J Rheumatol 2003; 30: 2620-2623
3. BONNEL RA, VILLALBA ML, KARWOSKY CB, BElTZ J: Deaths associated with inappropriate intravenous colchicine administration. J Emerg Med 2002; 22: 385-387
4. CENTERS TOR DISEASE CONTROL AND PREVENTION (CDC): Deaths from intravenous colchicine resulting from a compounding pharmacy error Oregon and Washington, 2007. MMWR 2007; 40: 1050-1052